March 7, 2023 12:30 PM EST
Pharma
Marketing

Mar­ket­ingRx roundup: Genen­tech dou­bles down on an­ti-racism; Eli Lil­ly rolls first so­cial video on $35 or less in­sulin

Beth Snyder Bulik

Senior Editor

Genen­tech is am­pli­fy­ing its com­mit­ment — and in­creas­ing its pledges — to counter sys­temic racism in health­care and ed­u­ca­tion. The Roche com­pa­ny and its Genen­tech Foun­da­tion re­cent­ly …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Io­n­is’ treat­ment for a rare meta­bol­ic dis­or­der

A service from the Financial Times